Dataset of Two-Dimensional Gel Electrophoresis Images of Acute Myeloid Leukemia Patients before and after Induction Therapy

Juan E. Urrea, Luisa F. Restrepo, Jeanette Prada-Arismendy, Erwing Castillo, Manuel M. Goez, Maria C. Torres-Madronero, Edilson Delgado-Trejos and Sarah Röthlisberger
Additional contact information
Juan E. Urrea: Measurement Analysis and Decision-Making Support Laboratory (AMYSOD Lab), Quality, Metrology and Production (CM&P) Research Group, Instituto Tecnologico Metropolitano (ITM), 76A354 Medellin, Colombia
Luisa F. Restrepo: Biomedical Research and Innovation Group (GI2B), Instituto Tecnologico Metropolitano ITM, 76A354 Medellin, Colombia
Jeanette Prada-Arismendy: Biomedical Research and Innovation Group (GI2B), Instituto Tecnologico Metropolitano ITM, 76A354 Medellin, Colombia
Erwing Castillo: Hematology and Oncology Unit, Hospital Manuel Uribe Angel, 38S57 Envigado, Colombia
Manuel M. Goez: Smart Machines and Pattern Recognition (MIRP) Research Group, Instituto Tecnologico Metropolitano ITM, 76A354 Medellin, Colombia
Maria C. Torres-Madronero: Smart Machines and Pattern Recognition (MIRP) Research Group, Instituto Tecnologico Metropolitano ITM, 76A354 Medellin, Colombia
Edilson Delgado-Trejos: Measurement Analysis and Decision-Making Support Laboratory (AMYSOD Lab), Quality, Metrology and Production (CM&P) Research Group, Instituto Tecnologico Metropolitano (ITM), 76A354 Medellin, Colombia
Sarah Röthlisberger: Biomedical Research and Innovation Group (GI2B), Instituto Tecnologico Metropolitano ITM, 76A354 Medellin, Colombia

Data, 2021, vol. 6, issue 2, 1-5

Abstract: Acute myeloid leukemia (AML) is a malignant disorder of the hematopoietic stem and progenitor cells, which results in the build-up of immature blasts in the bone marrow and eventually in the peripheral blood of affected patients. Accurately assessing a patient´s prognosis is very important for clinical management of the disease, which is why there are several prognostic factors such as age, performance status at diagnosis, platelet count, serum creatinine and albumin that are taken into account by the clinician when deciding the course of treatment. However, proteomic changes related to treatment response in this patient group have not been widely explored. Here, we make available a set of 22 two-dimensional gel electrophoresis (2DGE) images obtained from the peripheral blood samples of 11 patients with AML, taken at the time of diagnosis and after induction therapy (approximately 21–28 days after starting treatment). The same set of 2DGE images is also made available after a preprocessing stage (an additional 22 2DGE pre-processed images), which was performed using algorithms developed in Python, in order to improve the visualization of characteristic spots and facilitate proteomic analysis of this type of images.

Keywords: acute myeloid leukemia; image preprocessing; proteomics; two-dimensional gel electrophoresis (search for similar items in EconPapers)
JEL-codes: C8 C80 C81 C82 C83 (search for similar items in EconPapers)
Date: 2021
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/2306-5729/6/2/20/pdf (application/pdf)
https://www.mdpi.com/2306-5729/6/2/20/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jdataj:v:6:y:2021:i:2:p:20-:d:501035

Access Statistics for this article

Data is currently edited by Ms. Cecilia Yang

More articles in Data from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().